Where does Codexis, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Codexis, Inc. ranks #1,212 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Codexis, Inc. hold?

Codexis, Inc. holds 350 US utility patents granted between 2015 and 2025, spanning 26 technology areas.

What is Codexis, Inc.'s Innovation Score?

Codexis, Inc. has an Innovation Score of 52.1 out of 100 (top 11% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Codexis, Inc.'s patent grant rate increasing or decreasing?

Codexis, Inc.'s recent grant velocity is -12% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Codexis, Inc.'s patents?

Codexis, Inc.'s patents average 15.3 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Codexis, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Codexis, Inc.

Q: What technology areas does Codexis, Inc. focus on?

Codexis, Inc.'s top technology area is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media) with 346 patents, ranking #15 of 4,144 assignees active in that subclass. Grants appear in 26 CPC subclasses total.

USPTO PatentsView assignee record - 350 granted patents across 26 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Codexis ranks #1,212 of 49,997 tracked US assignees by granted-patent volume, with 350 patents across 26 technology areas.

#1,212
of 49,997 US assignees by volume: Top 11%
by Innovation Score (52.1/100): 15.3
avg claims per patent: -12%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R1212 · US Corporation #1,212 · 350 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-DOWN · BOOK-FULL

GRANTS-MID 350 grants
TOP-DECILE #1,212/49,997
PHOTO-FINISH Clarion
CPC-FOCUS C12N · 26 areas
INNOV-PAR 52.1/100
CLAIMS-RICH 15.3 claims/avg
TYPE-USCORP US Corporation
VEL-DOWN -12% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Clarion Co., Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Codexis’s 52.1 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 20.2 pts (39%) Velocity 4.7 pts (9%) Breadth 18.0 pts (35%) Claim depth 9.2 pts (18%)

Qualcomm Incorporated · highest

85
Gearbox · near

52
Hangzhou Glority… · near

52
Codexis · this assignee

52
Neptune Technology… · near

52
PricewaterhouseCoope… · near

52
3D Lighting… · lowest

7

What this shows Codexis's Innovation Score is 52.1/100 (top 11% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Codexis?

Each dot is one of Codexis’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Codexis’s own 15.3 claims/patent is ABOVE the 11.5 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Codexis vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Codexis's grants concentrate

Codexis, Inc. is a focused PatentsView assignee: 26 CPC subclasses with 98.9% of grants classified under C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media). Peak complete grant year is 2020 (40 grants) versus a trough of 21 in 2023. By volume, Codexis sits between Lumentum Operations LLC and JX Nippon Mining & Metals Corporation.

Codexis's three-year grant acceleration

From 2019–2021 to 2022–2024, Codexis, Inc. moved from 103 to 72 grants (0.70x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #2,156. See the growth leaderboard.

Lumentum Operatio…

351
Shanghai Tianma A…

351
Shenzhen Smoore T…

351
Clarion

350
Gamblit Gaming

350
Ii-vi Delaware

350
Jeol

350
JX Nippon Mining…

350
Codexis ◀

350

What this shows Codexis holds 350 patents at rank #1,212, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Codexis

By rank, the assignees closest to #1,212 in granted patent volume.

Leaders in C12N (Microorganisms OR Enzymes)

Other assignees with the most granted patents in Codexis's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Codexis, neither rank-band nor same-CPC leaders (those blocks stay above). In C12N (Microorganisms OR Enzymes), Codexis ranks #15 of 4,144 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (52 here).

Neptune Technology Group LLC 52 Gearbox, Inc. 52 Hangzhou Glority Software Limited 52 PricewaterhouseCoopers LLP 52

Similar claim depth

Nearest assignees by average claims per patent (15.3 here).

Semiconductor Manufacturing International (Shanghai) Corporation 15.3 avg Hanchett Entry Systems, Inc. 15.3 avg Seurat Technologies, Inc. 15.3 avg Focaltech Systems Co., Ltd. 15.3 avg

Codexis's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

52 Top 11% higher than 89% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Codexis, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	38	10.9%
2016	36	10.3%
2017	37	10.6%
2018	30	8.6%
2019	27	7.7%
2020	40	11.4%
2021	36	10.3%
2022	26	7.4%
2023	21	6.0%
2024	25	7.1%
2025partial year	34	9.7%

Which technologies does Codexis, Inc. patent most?

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 346

C12Y - Enzymes 323

C12P - Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture 275

Y02P - Climate Change Mitigation Technologies IN THE Production OR Processing OF Goods 143

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 58

C07K - Peptides 52

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 39

Y02E - Reduction OF Greenhouse GAS [GHG] Emissions, Related TO Energy Generation, Transmission OR Distribution 36

C07D - Heterocyclic Compounds 17

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 10

G16B - Bioinformatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR Genetic OR Protein-related Data Processing IN Computational Molecular Biology 7

C07C - Acyclic OR Carbocyclic Compounds 6

G16C - Computational CHEMISTRY; CHEMOINFORMATICS; Computational Materials Science 6

C11D - Detergent COMPOSITIONS; USE OF Single Substances AS DETERGENTS; Soap OR SOAP-MAKING; Resin SOAPS; Recovery OF Glycerol 5

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 4

Top 15 of 26 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Codexis, Inc.'s patent record in context - here's where to go next.

Codexis, Inc.'s lead technology class is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media), 98.9% of its portfolio - see every assignee active in that class. Explore C12N
Ranked #1,212 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Codexis, Inc. against Lumentum Operations LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 52.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.